Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

BIENERTOVÁ VAŠKŮ Julie TOMANDL Josef BIENERT Petr CHOVANEC Josef DOSTÁLOVÁ Zuzana VAŠKŮ Anna VALÍK Dalibor

Rok publikování 2011
Druh Článek v odborném periodiku
Časopis / Zdroj World Journal of Oncology
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.4021/wjon385w
Obor Onkologie a hematologie
Klíčová slova Agouti-related peptide; Cachexia; Cancer; Cancer survivors
Popis Recently, it has been reported that central administration of agouti-related peptide (AgRP) might have protective effect against cachexia development in tumor-bearing mice. In this study, we determined whether the disease-free endometrial cancer survivors present with different plasma AgRP levels than controls and whether there was an association with the duration of the disease- free interval. The total of 53 endometrial cancer survivors was enrolled in the study along with 93 healthy control women of similar age. Fasting blood samples were obtained and AgRP plasma levels determined using ELISA-based methodology. The AgRP plasma levels were signifi cantly higher in the cases than in the controls; AgRP levels were the lowest in obese control women; on the contrary, the AgRP plasma levels were highest in non-obese cancer survivors. Moreover, we observed signifi cant differences in AgRP levels between the endometrial cancer survivors and the control subjects [p (for comparison of the cases and the controls) = 0.002]. In the regression modeling, AgRP was signifi cantly associated with the BMI as well as the case-control status, and the case-control differences in AgRP levels retained their statistical signifi cance also after adjustment for BMI. Disease-free endometrial cancer survivors who did not develop cachexia during their treatment as well as post-treatment period present with signifi cantly higher AgRP levels than the control population, independently on their BMI and menopausal status which could be indicative of the protective effect of circulating AgRP against cachexia development in endometrial cancer.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info